M

Monopar Therapeutics
D

MNPR

18.450
USD
-1.01
(-5.19%)
مغلق
حجم التداول
4,070
الربح لكل سهم
0
العائد الربحي
0
P/E
-8
حجم السوق
64,950,753
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Monopar Therapeutics Inc

القطاع: Healthcare
الصناعة: Biotechnology
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists ofValidiveforthe prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.